๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Zurich
Clinical trial register · Switzerland

Clinical Trials in Zurich, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Switzerland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2252 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:47 UTC
2252
Studies in scope
all four open statuses
1374
Recruiting now
open to new participants
530
Lead sponsors
across recruiting studies
Top sites
Zurich 738 Bern 720 Basel 635 Geneva 402 Lausanne 394
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Zurich110 University Hospital, Basel, Switzerland26 Novartis Pharmaceuticals20 Insel Gruppe AG, University Hospital Bern20 University Children's Hospital, Zurich19
Site location
Zurich738 Bern720 Basel635 Geneva402 Lausanne394
All 149 locations
Target enrolment
to

Trials with a site in Zurich

738 of 2252 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Switzerland
Start
Not yet open
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
NCT07476729B-Cell Acute Lymphoblastic Leukaemia
DrugsInotuzumab Ozogamicin·Blinatumomab
Charite University, Berlin, Germany
Phase 3
750
Zurich
2026-04-01
Recruiting
Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
NCT06710210Coronary Artery Disease, Diffuse Coronary Artery Disease, Percutaneous Coronary Intervention (PCI)
University Hospital, Geneva
Not applicable
150
Geneva, Basel, Bern, Zurich
2026-04-01
Not yet open
Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot Study
NCT07421947Coronary Artery Disease, Type 2 Diabetes Mellitus (T2DM)
DrugFecal Microbiota Transplantation
University of Zurich
Not applicable
30
Zurich
2026-04
Not yet open
Evaluation of Radiation-Free Caries Detection Integrated Into Intraoral Scanners Compared With Conventional Diagnostic Methods
NCT07342595Caries Assessment, Caries; Dentin, Caries; Initial
Albert Mehl
Not applicable
50
Zurich
2026-04
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
NCT07440225Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration
DrugsTiespectus·Eylea·Aflibercept
EyeBiotech Ltd.
Phase 2/3
960
Basel, Bern, Binnigen, Lausanne, Zurich
2026-03-27
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
NCT07293351Advanced Renal Cell Carcinoma (RCC)
DrugsCasdatifan·Pumitamig·Cabozantinib·Ipilimumab
Bristol-Myers Squibb
Phase 1/2
474
Chur, Sankt Gallen, Zurich
2026-03-26
Recruiting
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
NCT07355296Proteinuric Kidney Diseases
DrugApecotrep
Boehringer Ingelheim
Phase 2
132
Zurich
2026-03-23
Recruiting
Effect of Acute Hypoxia on RIght VEntRicular Function in HAPE.
NCT07431554Altitude Hypoxia, Hypoxia, Normobaric Hypoxia, Right Ventricular Function
Mona Lichtblau
Not applicable
18
Zurich
2026-03-17
Active, closed
Emotional-distress-based Integrated Care Programme in Patients With Stable COPD
NCT07524023COPD, COPD (Chronic Obstructive Pulmonary Disease)
University of Zurich
Not applicable
15
Zurich
2026-03-16
Recruiting
Effect of Acute Hypoxia on RIght VEntRicular Function in Healthy Adults.
NCT07431567Hypoxia, Normobaric Hypoxia, Altitude Hypoxia, Right Heart Function
Mona Lichtblau
Not applicable
18
Zurich
2026-03-11
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
NCT07438496Lupus Erythematosus, Systemic
DrugNipocalimab
Janssen Research & Development, LLC
Phase 3
600
Basel, Geneva, Zurich
2026-03-05
Recruiting
Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation
NCT07430943Pulmonary Rehabilitation, Physical Activities, Exercise Therapy
Mona Lichtblau
Not applicable
12
Zurich
2026-03-05
Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
NCT07223814Acute Myeloid Leukemia
DrugsBleximenib·Idarubicin·Daunorubicin·Cytarabine
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Bern, Fribourg, Geneva, Sankt Gallen, Zurich
2026-03-01
Not yet open
Post-Market Study of Transbronchial Cryo-assisted RFA During Robotic Bronchoscopy With Subsequent Surgical Resection
NCT07398027Lung Cancer
Carolin Steinack
Not applicable
20
Zurich
2026-03
Recruiting
Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency
NCT07394972Iron Deficiency (Without Anemia)
Nicole Stoffel
Not applicable
45
Zurich
2026-02-17
Recruiting
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
NCT07220083Focal Segmental Glomerulosclerosis
DrugApecotrep
Boehringer Ingelheim
Phase 3
286
Bern, Zurich
2026-02-16
Recruiting
SwissNeuroRehab - HDHI
NCT07427511Stroke
Centre Hospitalier Universitaire Vaudois
Not applicable
120
Vitznau, Valens, Lausanne, Sullens, Zurich
2026-02-10
Recruiting
Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents
NCT06852313Ovarian Cyst Benign
University Children's Hospital, Zurich
Not applicable
80
Basel, Zurich
2026-02-05
Recruiting
Robotic-Assisted Versus Conventional Bronchoscopy for Cryobiopsy in the Diagnosis of Interstitial Lung Disease
NCT07500818Interstitial Lung Disease (ILD), Lung Biopsy
University of Zurich
Not applicable
30
Lucerne, Zurich
2026-02-01
Recruiting
Evaluating Symptom Variations and Observing Longitudinal Individual Change Effects in TF-CBT
NCT07402681Post-traumatic Stress Symptoms
University Children's Hospital, Zurich
Observational
21
Zurich
2026-02
Recruiting
Speech-based Assessment of Relapse Risk in People With Psychosis
NCT07397975Psychotic Disorder
Philipp Homan
Observational
360
Geneva, Zurich
2026-01-29
Active, closed
PICO Negative Pressure for Uninfected Foot Ulcers and Wound Dehiscence (BALPIC)
NCT07398534Wound Dehiscence, Wound
Ilker Uckay
Not applicable
300
Zurich
2026-01-29
Recruiting
Steroid Use in Treatment of Allergic Reactions to Food
NCT07341776Anaphylactic Reaction, Anaphylaxis, Allergy in Children, IgE Mediated Food Allergy
DrugsLevocetirizine·Systemic corticosteroids·Betamethasone·Adrenaline
Johannes Trueck
Phase 4
160
Basel, Zurich
2026-01-26
Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
NCT07015190Uveal Melanoma
DrugDarovasertib
IDEAYA Biosciences
Phase 3
520
Basel, Zurich
2026-01-25
Recruiting
Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322IDH-mutant Grade 2 or 3 Astrocytoma
DrugVorasidenib
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
468
Basel, Zurich
2026-01-16
Recruiting
Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
NCT07058805Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma
Olgun Elicin
Phase 2
50
Basel, Bern, Zurich
2026-01-15
Recruiting
Role of Slow Waves in the Progression of Neurodegeneration in Isolated REM Sleep Behavior Disorder
NCT07355842Parkinson Disease, REM Sleep Behavior Disorder (iRBD)
University of Zurich
Not applicable
80
Zurich
2026-01-15
Active, closed
Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD
NCT07351929COPD Exacerbation
University of Zurich
Not applicable
20
Zurich
2026-01-12
Recruiting
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT07179380Pulmonary Hypertension, Interstitial Lung Disease
DrugTreprostinil Palmitil
Insmed Incorporated
Phase 3
344
Basel, Zurich
2026-01-07
Active, closed
A New Landmark-formula for Cephalic Vein in Children
NCT07333846Venipuncture, Ultrasound, Difficult Intravenous Access in Pediatrics, Pediatric Anesthesia
Alexander Schmidt
Observational
75
Zurich
2026-01-06
Recruiting
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
NCT07219043Microvascular Inflammation
DrugFelzartamab
Biogen
Phase 2
81
Zurich
2026-01-05
Recruiting
Trial on the Impact of Indirect Calorimetry-Guided Nutritional Support on Patient-Centered Outcomes in Critically Ill Patients - The OPTICal Study
NCT07343440Critical Illness, ICU
HEIDEGGER CP
Not applicable
356
Geneva, Nyon, Zurich
2026-01-01
Not yet open
Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
NCT07160959Chronic Kidney Disease (Stages 4 and 5), Mild Cognitive Impairment (MCI)
Biogem s.c.ar.l.
Not applicable
124
Zurich
2026-01-01
Not yet open
Sevoflurane Sedation in Patients With Septic Shock
NCT03643367Shock, Septic
DrugsSevoflurane·Propofol
University of Zurich
Phase 2
153
Mรผnsterlingen, Zurich
2026-01
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRฮฑ-high and AZD5335 vs. Chemotherapy in FRฮฑ-low Platinum-resistant Ovarian Cancer
NCT07218809Epithelial Ovarian Cancer
DrugsTorvutatug samrotecan·MIRV·Mirvetuximab Soravtansine·Pegylated liposomal doxorubicin
AstraZeneca
Phase 3
1,100
Basel, Mรผnsterlingen, Sankt Gallen, Thun, Zollikerberg, Zurich
2025-12-29
Recruiting
Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya
NCT07315295Iron Absorption, Iron Deficiencies, Severly Acutely Malnourished Children, Malnutrition in Children
ETH Zurich
Not applicable
68
Zurich
2025-12-23
Recruiting
Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
NCT07143539Venous Thromboembolism (VTE), Exercise Therapy, Quality of Life (QOL), Anxiety Depression
Insel Gruppe AG, University Hospital Bern
Not applicable
160
Aarau, Baden, Bern, Geneva, Lausanne, Zurich
2025-12-17
Recruiting
Development of the PTSD-iMPACT to Measure PTSD-Related Functional Impairment in Children and Adolescents - A Validation Study in Switzerland and Germany
NCT07368166PTSD - Post Traumatic Stress Disorder, PTSD-Related Functional Impairment in Children and Adolescents
University Children's Hospital, Zurich
Observational
1,200
Frauenfeld, Sankt Gallen, Winterthur, Zurich
2025-12-15
Recruiting
Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
NCT07309497Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, CART Therapy, Bispecific Antibody, Geriatric Hematology
University of Zurich
Observational
208
Bern, Zurich
2025-12-12
Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779Ovarian Cancer
DrugINCB123667
Incyte Corporation
Phase 3
466
Bellinzona, Chur, Frauenfeld, Geneva, Lausanne, Zurich
2025-12-09
Not yet open
Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis
NCT05105958Amyotrophic Lateral Sclerosis
DrugTideglusib
University of Zurich
Phase 2
98
Bern, Geneva, Lausanne, Sankt Gallen, Zurich
2025-12-01
Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naรฏve Metastatic Castration-resistant Prostate Cancer
NCT07213674Metastatic Castration-resistant Prostate Cancer
DrugsXaluritamig·Cabazitaxel·Abiraterone acetate·Docetaxel
Amgen
Phase 3
750
Bern, Lausanne, Sankt Gallen, Zurich
2025-11-28
By invitation
Optical Coherence Tomography in Acute Vessel Evaluation
NCT07422688Ischemic Heart Disease, Ischemic Coronary Artery Disease, ACS (Acute Coronary Syndrome)
Aarhus University Hospital Skejby
Not applicable
3,000
Zurich
2025-11-23
Recruiting
Pulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation
NCT07237139Infant, Preterm, Respiratory Distress Syndrome (Neonatal), Chronic Lung Disease of Newborn, Respiratory Support
University of Zurich
Observational
27
Zurich
2025-11-17
Recruiting
Masseter Muscle Stiffness After Heat Application and Percussion Therapy
NCT07237087Healthy Participants
University of Zurich
Not applicable
40
Zurich
2025-11-15
Recruiting
TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System
NCT07568483Tobacco Use Disorder, Nicotine Dependence, Vaping, Smoking Tobacco
University of Zurich
Not applicable
406
Zurich
2025-11-15
Recruiting
Impact of Chronic and Acute Caffeine Intake on the Hematopoietic System
NCT07193264Healthy Adults; Hematopoietic System; Caffeine
Jasmin Rettkowski
Not applicable
100
Zurich
2025-11-05
Recruiting
Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
NCT07263438Glioblastoma, Recurrence Tumor
DrugsAtezolizumab·Bevacizumab
Centre Hospitalier Universitaire Vaudois
Phase 2
59
Basel, Aarau, Bern, Fribourg, Lucerne, Lausanne, Zurich
2025-11-03
Recruiting
STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
NCT05785897ST Elevation Myocardial Infarction
IGLESIAS Juan Fernando
Not applicable
350
Geneva, Zurich
2025-11-01
Not yet open
Effects of Cerebrospinal Fluid Drainage on Cerebral Hemodynamics
NCT07056907Acute Ischemic Stroke
University of Zurich
Not applicable
30
Zurich
2025-11-01
Recruiting
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPSโ‰ฅ1) HNSCC
NCT07026474Recurrent Head and Neck Squamous Cell Carcinoma
DrugsAdrucil·Cisplatin·Pembrolizumab
Universitรคt des Saarlandes
Phase 3
214
Zurich
2025-10-30
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
NCT06659445Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
DrugAvacincaptad Pegol
ONL Therapeutics
Phase 2
324
Bern, Binningen, Lausanne, Zurich
2025-10-28
Recruiting
Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
NCT06835049Sarcoma,Soft Tissue
DrugsDacarbazine·Ifosfamide·Doxorubicin
Swiss Cancer Institute
Phase 2
24
Aarau, Basel, Bellinzona, Bern, Lausanne, Sankt Gallen, Winterthur, Zurich
2025-10-27
Recruiting
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
NCT06405087Ulcerative Colitis, Crohn's Disease
DrugVedolizumab
Takeda
Phase 3
70
Bern, Lausanne, Zurich
2025-10-27
Active, closed
Liver Metabolic Functions in Patients With Citrin Deficiency and Healthy Subjects
NCT07055269Citrin Deficiency
Johannes Haeberle
Not applicable
20
Zurich
2025-10-20
Recruiting
Multimodality Cardiac Imaging for Disease Progression in ATTR-CM
NCT07112066Amyloidosis Cardiac
Dominik Benz
Not applicable
50
Zurich
2025-10-20
Recruiting
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
NCT07190248Non-small Cell Lung Cancer
Drugs) Berahyaluronidase alfa·Calderasib·Pemetrexed·Cisplatin
Merck Sharp & Dohme LLC
Phase 3
675
Zurich
2025-10-08
Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
NCT07196748Colitis, Ulcerative
DrugIcotrokinra
Janssen Research & Development, LLC
Phase 3
882
Bern, Sankt Gallen, Zurich
2025-10-01
Recruiting
COMS for Chronic Ulcers Treatment
NCT06528873Venous Leg Ulcer, Wound Heal, Magnetic Field Exposure
Sebastian Probst
Phase 4
122
Delรฉmont, Kreuzlingen, Onex, Thun, Zurich
2025-10-01
Active, closed
Underweight, Overweight, and Linear Growth of Childhood Cancer Patients - the Growth Study
NCT07750444Childhood Cancer
Fabiรซn Belle
Observational
12,150
Aarau, Basel, Bern, Geneva, Lucerne, Sankt Gallen, Zurich, Bellinzona
2025-10-01
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
NCT07106762Urothelial Cancer
DrugsIza-bren·Gemcitabine·Cisplatin·Carboplatin
Bristol-Myers Squibb
Phase 2/3
470
Sankt Gallen, Bellinzona, Chur, Zurich
2025-09-30
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
400
Aarau, Basel, Geneva, Neuchรขtel, Sankt Gallen, Zurich
2025-09-13
Recruiting
Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases
NCT06620380Brain Metastases, Brain Metastases, Adult
University of Zurich
Phase 2
102
Basel, Sankt Gallen, Zurich
2025-09-12
Recruiting
European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castorโ„ข and Cratosโ„ข
NCT07668687Dissection of Thoracic Aorta, Dissection of Thoracic Descending Aorta, Aneurysm of Aorta, Thoracic, Penetrating Aortic Ulcers (PAUs)
Shanghai MicroPort Endovascular MedTech๏ผˆGroup๏ผ‰Co., Ltd
Observational
100
Sion, Zurich
2025-09-12
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT06926868Breast Neoplasms
DrugsIza-bren·Nab-paclitaxel·Capecitabine·Gemcitabine
Bristol-Myers Squibb
Phase 2/3
600
Sankt Gallen, Lausanne, Zurich
2025-09-11
Recruiting
Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure.
NCT07029230Congenital Heart Surgery, Congenital Heart Disease in Children, Fontan Physiology
Martin Schweiger
Observational
225
Zurich
2025-09-10
Recruiting
European Real-World Registry for Use of the Ion Endoluminal System
NCT06923774Pulmonary Nodule, Lung Cancer
Intuitive Surgical
Observational
1,200
Zurich
2025-09-09
Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT06973187Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsTacabrutideg·Pirtobrutinib
BeOne Medicines
Phase 3
500
Bern, Zurich
2025-09-04
Recruiting
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
NCT07136467Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa
AbbVie
Observational
2,795
Aarau, Basel Town, Geneva, Lucerne, Zurich, Bellinzona, Lugano, Orsiรจres
2025-09-02
Not yet open
First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced Immunosuppression
NCT06258291Septic Shock
hemotune AG
Not applicable
16
Bern, Zurich
2025-09-01
Recruiting
Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease
NCT07102823Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hypertension
Medical University of Graz
Observational
1,000
Zurich
2025-09-01
Active, closed
Artificial Intelligence in Trapeziometacarpal Joint Osteoarthritis: Improving Assessment and Clinical Decision-Making
NCT07148349Thumb Osteoarthritis
Schulthess Klinik
Observational
2,500
Zurich
2025-09-01
Not yet open
SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New
NCT06931847Cancer
Biobizkaia Health Research Institute
Observational
4,000
Zurich
2025-09
Not yet open
The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program
NCT06922201Cancer
Biobizkaia Health Research Institute
Not applicable
3,500
Zurich
2025-09
Not yet open
Is Intraoperative PTH Monitoring Obsolete in Times of Choline PET/CT? a Prospective Multicenter Cohort Study to Determine Whether the Regular Preoperative Use of Choline-PET/CT Scan Obviate the Need for Intraoperative PTH-measurement in Patients with Primary Hyperparathyreoidism
NCT06804681Primary Hyperparathyroidism
University of Zurich
Observational
1,000
Zurich
2025-09
Recruiting
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
NCT07200908Chronic Hepatitis D Infection
DrugBrelovitug
Mirum Pharmaceuticals, Inc.
Phase 3
172
Geneva, Sankt Gallen, Zurich
2025-08-27
Recruiting
Determination of Iron Absorption and Losses in People Living at High Altitude to Investigate the Requirements in This Population Group Using a Newly Developed Technique
NCT07142590Iron Absorption, Iron Requirements, Altitude
Diego Moretti
Not applicable
120
Zurich
2025-08-22
Recruiting
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
NCT06960382Allergic Rhinitis, Allergic Asthma
University of Zurich
Phase 1/2
36
Zurich
2025-08-20
By invitation
Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)
NCT06898086Severe Aortic Stenosis
Rede Optimus Hospitalar SA
Not applicable
620
Basel, Zurich
2025-08-08
Recruiting
Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
NCT06680050Non Small Cell Lung Cancer NSCLC
DrugsCeralasertib·Durvalumab
Mario Negri Institute for Pharmacological Research
Phase 2
21
Geneva, Zurich
2025-08-07
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
NCT07075016Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Basel, Bellinzona, Bern, Zurich
2025-08-05
Recruiting
HOPE Against Cancer Recurrence in HCC
NCT06717919Liver Transplantation, HCC, Oncological Outcomes
Philipp Dutkowski
Phase 4
220
Basel, Zurich, Geneva
2025-08-01
Active, closed
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
NCT07044297Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
DrugMK-8527
Merck Sharp & Dohme LLC
Phase 3
4,390
Basel, Bern, Zurich
2025-07-31
Recruiting
MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery
NCT06815289Primary Lung Cancer or Secondary Lung Metastases
University of Zurich
Not applicable
11
Zurich
2025-07-31
Not yet open
Additively Versus Subtractively Manufactured Implant Supported Fixed Dental Prostheses
NCT07090863Dental Prosthesis, Implant-Supported
Harvard Medical School (HMS and HSDM)
Not applicable
50
Zurich
2025-07-30
Active, closed
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT06808217Atrial Fibrillation, Pulsed Field Ablation, FARAPULSE
Boston Scientific Corporation
Observational
550
Lugano, Zurich
2025-07-30
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433Atherosclerotic Cardiovascular Disease, Overweight, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
12,800
Basel, Bern, Geneva, Lausanne, Lugano, Zurich
2025-07-25
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsSigvotatug vedotin·Pembrolizumab
Pfizer
Phase 3
714
Bern, Zurich
2025-07-23
Recruiting
EASi-PROTKTโ„ข - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
DrugsVicadrostat·Dapagliflozin
Boehringer Ingelheim
Phase 3
11,800
Basel, Lausanne, Lucerne, Lugano, Sankt Gallen, Zurich
2025-07-22
Active, closed
Magnetic Resonance Imaging-guided Online Adaptive Radiotherapy of Pelvic Lymph Node Metastases
NCT07083648Pelvic and Para-aortic Lymph Node Metastases
University of Zurich
Not applicable
20
Zurich
2025-07-16
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
NCT06963827Kidney Disease
DrugMezagitamab
Takeda
Phase 3
347
Zurich
2025-07-15
Recruiting
Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal
NCT06872593Excessive Daytime Sleepiness, Obstructive Sleep Apnea (OSA), CPAP Treatment, Driving Simulator Performance
Stefan Lakรคmper
Not applicable
54
Zurich
2025-07-14
Recruiting
Personalized Stimulation Loop for Neurorehabilitation in Parkinson: a Proof-of-principle Study
NCT07082595Parkinson Disease
University of Zurich
Not applicable
40
Zurich
2025-07-07
Recruiting
Rotator Cuff Tendon Repair With FiberLocker System Patch Augmentation
NCT07005063Rotator Cuff Tear, Rotator Cuff Injury, Rotator Cuff Rupture
ZuriMED Technologies AG
Not applicable
50
Zurich
2025-07-03
Not yet open
Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis
NCT05647096Sepsis, Respiratory Failure
Santersus AG
Not applicable
73
Zurich
2025-07-01
Recruiting
Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music
NCT07028983Substance Use Disorder (SUD)
NORCE Norwegian Research Centre AS
Not applicable
600
Zurich
2025-07-01
Recruiting
Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
NCT06963203Graves Disease, Amiodarone-Induced Thyrotoxicosis, Thyroidectomy
Andrea Goldmann
Observational
486
Zurich, Basel, Bern, Geneva, Lausanne, Liestal, Mรคnnedorf, Mendrisio
2025-07-01
Recruiting
Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device
NCT06813859Fetal Distress
Balgrist University Hospital
Observational
20
Zurich
2025-06-30
Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
NCT06846281Relapsing Multiple Sclerosis
DrugsRemibrutinib·Ocrelizumab
Novartis Pharmaceuticals
Phase 3
400
Bern, Lausanne, Zurich
2025-06-23
Recruiting
Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)
NCT07472972Lymphoma, Lymphoid Hematological Malignancies
University of Zurich
Observational
50
Zurich
2025-06-20
Rows per page Showing 101–200 of 738
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swiss investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-switzerland/city/zurich?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Switzerland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,252 studies in total at the last sync on 26 Sep 2026, 19:47 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 738 of those studies with a site in Zurich.

How many clinical trials are recruiting in Zurich?

422 of the 738 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:47 UTC sync. A further 70 have not yet opened recruitment, 227 are active but closed to new participants, and 19 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.